Secondary lymphoid organ homing phenotype of human myeloid dendritic cells disrupted by an intracellular oral pathogen

Infection and Immunity

Volumn 82, Issue 1, 2014, Pages 101-111

  Miles, Brodie ^a   Zakhary, Ibrahim ^b   El Awady, Ahmed ^b   Scisci, Elizabeth ^a   Carrion, Julio ^a   O'Neill, John C ^b   Rawlings, Aaron ^b   Kobi Stern, J ^b   Susin, Cristiano ^b   Cutler, Christopher W ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b AUGUSTA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIUM CULTURE; CELL MIGRATION; CELLULAR IMMUNITY; CHEMOTAXIS; CHRONIC PERIODONTITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE HOMING; LYMPHOID ORGAN; MONOCYTE; MYELOID DENDRITIC CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL;

EID: 84890845621     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01157-13     Document Type: Article

References (77)

1. Hajishengallis G, Darveau RP, Curtis MA. 2012. The keystone-pathogen hypothesis. Nat. Rev. Microbiol. 10:717-725. http://dx.doi.org/10.1038/nrmicro2873.
2. Albandar, J. M. 2005. Epidemiology and risk factors of periodontal diseases. Dent. Clin. North Am. 49:517-532, v-vi.
3. Offenbacher S, Madianos PN, Champagne CME, Southerland JH, Paquette DW, Williams RC, Slade G, Beck JD. 1999. Periodontitisatherosclerosis syndrome: an expanded model of pathogenesis. J. Periodontal Res. 34:346-352. http://dx.doi.org/10.1111/j.1600-0765.1999.tb02264.x.
4. Holt SC, Kesavalu L, Walker S, Genco CA. 1999. Virulence factors of Porphyromonas gingivalis. Periodontol. 2000 20:168-238. http://dx.doi.org/10.1111/j.1600-0757.1999.tb00162.x.
5. Darveau RP. 2010. Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 8:481-490. http://dx.doi.org/10.1038/nrmicro2337.
6. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y-J, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767. http://dx.doi.org/10.1146/annurev.immunol.18.1.767.
7. Shortman K, Liu Y-J. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-161. http://dx.doi.org/10.1038/nri746.
8. Chen M, Wang Y-H, Wang Y, Huang L, Sandoval H, Liu Y-J, Wang J.2006. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311:1160-1164. http://dx.doi.org/10.1126/science.1122545.
9. Ishibashi S, Maric D, Mou Y, Ohtani R, Ruetzler C, Hallenbeck JM. 2009. Mucosal tolerance to E-selectin promotes the survival of newly generated neuroblasts via regulatory T-cell induction after stroke in spontaneously hypertensive rats. J. Cereb. Blood Flow Metab. 29:606-620. http://dx.doi.org/10.1038/jcbfm.2008.153.
10. Dieu-Nosjean MC, Vicari A, Lebecque S, Caux C. 1999. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J. Leukoc. Biol. 66:252-262.
11. Sozzani S, Allavena P, Vecchi A, Mantovani A. 1999. The role of chemokines in the regulation of dendritic cell trafficking. J. Leukoc. Biol. 66:1-9.
12. Cutler CW, Jotwani R, Palucka KA, Davoust J, Bell D, Banchereau J. 1999. Evidence and a novel hypothesis for the role of dendritic cells andPorphyromonas gingivalis in adult periodontitis. J. Periodontal Res. 34: 406-412. http://dx.doi.org/10.1111/j.1600-0765.1999.tb02274.x.
13. Iwasaki A. 2007. Mucosal dendritic cells. Annu. Rev. Immunol. 25:381-418. http://dx.doi.org/10.1146/annurev.immunol.25.022106.141634.
14. Luster AD, Alon R, von Andrian UH. 2005. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6:1182-1190. http://dx.doi.org/10.1038/ni1275.
15. Fainaru O, Shseyov D, Hantisteanu S, Groner Y. 2005. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc. Natl. Acad. Sci. U.S.A. 102:10598-10603. http://dx.doi.org/10.1073/pnasn.0504787102.
16. Cutler CW, Jotwani R. 2004. Antigen-presentation and the role of dendritic cells in periodontitis. Periodontol. 2000 35:135-157. http://dx.doi.org/10.1111/j.0906-6713.2004.003560.x.
17. Cutler CW, Teng Y-TA. 2007. Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists. Periodontol. 2000 45:35-50. http://dx.doi.org/10.1111/j.1600-0757.2007.00222.x.
18. Niessner A, Weyand CM. 2010. Dendritic cells in atherosclerotic disease. Clin. Immunol. 134:25-32. http://dx.doi.org/10.1016/j.clim.2009.05.006.
19. Scannapieco FA, Bush RB, Paju S. 2003. Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann. Periodontol. 8:38-53. http://dx.doi.org/10.1902/annals.2003.8.1.38.
20. Jiao X, Lo-Man R, Guermonprez P, Fiette L, Dériaud E, Burgaud S, Gicquel B, Winter N, Leclerc C. 2002. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 168:1294-1301.
21. Nagl M, Kacani L, Müllauer B, Lemberger E-M, Stoiber H, Sprinzl GM, Schennach H, Dierich MP. 2002. Phagocytosis and killing of bacteria by professional phagocytes and dendritic cells. Clin. Diagn. Lab. Immunol. 9:1165-1168.
22. Carrion J, Scisci E, Miles B, Sabino GJ, Zeituni AE, Gu Y, Bear A, Genco CA, Brown DL, Cutler CW. 2012. Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential. J. Immunol. 189:3178-3187. http://dx.doi.org/10.4049/jimmunol.1201053.
23. Zeituni AE, McCaig W, Scisci E, Thanassi DG, Cutler CW. 2010. The native 67-kilodalton minor fimbria of porphyromonas gingivalis is a novel glycoprotein with DC-SIGN-targeting motifs. J. Bacteriol. 192:4103-4110. http://dx.doi.org/10.1128/JB.00275-10.
24. Zeituni AE, Jotwani R, Carrion J, Cutler CW. 2009. Targeting of DC-SIGN on human dendritic cells by minor fimbriated Porphyromonas gingivalis strains elicits a distinct effector T cell response. J. Immunol.183:5694-5704. http://dx.doi.org/10.4049/jimmunol.0901030.
25. Scannapieco FA. 1999. Role of oral bacteria in respiratory infection. J. Periodontol. 70:793-802. http://dx.doi.org/10.1902/jop.1999.70.7.793.
26. Dorn BR, Dunn WA, Progulske-Fox A. 2001. Porphyromonas gingivalis traffics to autophagosomes in human coronary artery endothelial cells. Infect. Immun. 69:5698-5708. http://dx.doi.org/10.1128/IAI.69.9.5698-5708.2001.
27. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA, Progulske-Fox A. 2005. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler. Thromb. Vasc. Biol. 25:e17-e18. http://dx.doi.org/10.1161/01.ATV.0000155018.67835.1a.
28. Liao F, Li Z, Wang Y, Shi B, Gong Z, Cheng X. 2009. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitisassociated rheumatoid arthritis. Med. Hypotheses 72:732-735. http://dx.doi.org/10.1016/j.mehy.2008.12.040.
29. Xu J, Mahowald MA, Ley RE, Lozupone CA, Hamady M, Martens EC, Henrissat B, Coutinho PM, Minx P, Latreille P, Cordum H, Van Brunt A, Kim K, Fulton RS, Fulton LA, Clifton SW, Wilson RK, Knight RD, Gordon JI. 2007. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol. 5:e156. http://dx.doi.org/10.1371/journal.pbio.0050156.
30. Randolph GJ, Ochando J, Partida-Sanchez S. 2008. Migration of dendritic cell subsets and their precursors. Annu. Rev. Immunol. 26:293-316. http://dx.doi.org/10.1146/annurev.immunol.26.021607.090254.
31. Dieu M-C, Vanbervliet B, Vicari A, Bridon J-M, Oldham E, Aït-Yahia S, Brière F, Zlotnik A, Lebecque S, Caux C. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188:373-386. http://dx.doi.org/10.1084/jem.188.2.373.
32. Forster R, Davalos-Misslitz AC, Rot A. 2008. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8:362-371. http://dx.doi.org/10.1038/nri2297.
33. Pulendran B, Banchereau J, Maraskovsky E, Maliszewski C. 2001. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol. 22:41-47. http://dx.doi.org/10.1016/S1471-4906(00)01794-4.
34. Ohtani T, Mizuashi M, Nakagawa S, Sasaki Y, Fujimura T, Okuyama R, Aiba S. 2009. TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation. Immunology 126:485-499. http://dx.doi.org/10.1111/j.1365-2567.2008.02919.x.
35. McGrath KE, Koniski AD, Maltby KM, McGann JK, Palis J. 1999. Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev. Biol. 213:442-456. http://dx.doi.org/10.1006/dbio.1999.9405.
36. Ma Q, Jones D, Springer TA. 1999. The chemokine receptor CXCR4 is required for the retention of b lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10:463-471. http://dx.doi.org/10.1016/S1074-7613(00)80046-1.
37. Lee B, Sharron M, Montaner LJ, Weissman D, Doms RW. 1999. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. U.S.A. 96:5215-5220. http://dx.doi.org/10.1073/pnas.96.9.5215.
38. Luster AD. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436-445. http://dx.doi.org/10.1056/NEJM199802123380706.
39. Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J, Taichman R, Pienta K, Wang J. 2010. CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev. 29:709-722. http://dx.doi.org/10.1007/s10555-010-9256-x.
40. Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L, Shim H. 2005. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 65:967-971.
41. Chapple CC, Kumar RK, Hunter N. 2000. Vascular remodelling in chronic inflammatory periodontal disease. J. Oral Pathol. Med. 29:500-506. http://dx.doi.org/10.1034/j.1600-0714.2000.291004.x.
42. Jotwani R, Muthukuru M, Cutler CW. 2004. Increase in HIV receptors/co-receptors/+-defensins in inflamed human gingiva. J. Dent. Res. 83:371-377. http://dx.doi.org/10.1177/154405910408300504.
43. Havens AM, Chiu E, Taba M, Wang J, Shiozawa Y, Jung Y, Taichman LS, D'Silva NJ, Gopalakrishnan R, Wang C, Giannobile WV, Taichman RS. 2008. Stromal-derived factor-1alpha (CXCL12) levels increase in periodontal disease. J. Periodontol. 79:845-853. http://dx.doi.org/10.1902/jop.2008.070514.
44. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Murakami K, Miyake Y, Matsuo T. 2005. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease. Clin. Exp. Immunol. 141:467-474. http://dx.doi.org/10.1111/j.1365-2249.2005.02852.x.
45. Kuboniwa M, Amano A, Hashino E, Yamamoto Y, Inaba H, Hamada N, Nakayama K, Tribble G, Lamont R, Shizukuishi S. 2009. Distinct roles of long/short fimbriae and gingipains in homotypic biofilm development by Porphyromonas gingivalis. BMC Microbiol. 9:105. http://dx.doi.org/10.1186/1471-2180-9-105.
46. Malek R, Fisher JG, Caleca A, Stinson M, van Oss CJ, Lee JY, Cho MI, Genco RJ, Evans RT, Dyer DW. 1994. Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J. Bacteriol. 176:1052-1059.
47. Njoroge T, Genco RJ, Sojar HT, Hamada N, Genco CA. 1997. A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect. Immun. 65:1980-1984.
48. Tuominen-Gustafsson H, Penttinen M, Hytonen J, Viljanen MK. 2006. Use of CFSE staining of borreliae in studies on the interaction between borreliae and human neutrophils.BMCMicrobiol. 6:92. http://dx.doi.org/10.1186/1471-2180-6-92.
49. Cutler CW, Kalmar JR, Arnold RR. 1991. Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G. Infect. Immun. 59:2097-2104.
50. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC. 1997. Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 27:431-441. http://dx.doi.org/10.1002/eji.1830270213.
51. Jotwani R, Pulendran B, Agrawal S, Cutler CW. 2003. Human dendriticcells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro. Eur. J. Immunol. 33:2980-2986. http://dx.doi.org/10.1002/eji.200324392.
52. Vegh Z, Kew RR, Gruber BL, Ghebrehiwet B. 2006. Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR. Mol. Immunol. 43:1402-1407. http://dx.doi.org/10.1016/j.molimm.2005.07.030.
53. Donzella GA, Schols D, Lin SW, Este JA, Nagashima KA, Maddon PJ, Allaway GP, Sakmar TP, Henson G, De Clercq E, Moore JP. 1998. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat. Med. 4:72-77. http://dx.doi.org/10.1038/nm0198-072.
54. Zigmond SH, Hirsch JG. 1973. Leukocyte locomotion and chemotaxis. J. Exp. Med. 137:387-410. http://dx.doi.org/10.1084/jem.137.2.387.
55. Osterholzer JJ, Ames T, Polak T, Sonstein J, Moore BB, Chensue SW, Toews GB, Curtis JL. 2005. CCR2 and CCR6, but not endothelial selectins, mediate the accumulation of immature dendritic cells within the lungs of mice in response to particulate antigen. J. Immunol. 175:874-883.
56. Jotwani R, Cutler CW. 2004. Fimbriated Porphyromonas gingivalis is more efficient than fimbria-deficient P. gingivalis in entering human dendritic cells in vitro and induces an inflammatory Th1 effector response. Infect. Immun. 72:1725-1732. http://dx.doi.org/10.1128/IAI.72.3.1725-1732.2004.
57. Bergman MP, Engering A, Smits HH, van Vliet SJ, van Bodegraven AA, Wirth H-P, Kapsenberg ML, Vandenbroucke-Grauls CMJE, van Kooyk Y, Appelmelk BJ. 2004. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med. 200:979-990. http://dx.doi.org/10.1084/jem.20041061.
58. Geijtenbeek TBH, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GCF, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597. http://dx.doi.org/10.1016/S0092-8674(00)80694-7.
59. Soilleux EJ, Sarno EN, Hernandez MO, Moseley E, Horsley J, Lopes UG, Goddard MJ, Vowler SL, Coleman N, Shattock RJ, Sampaio EP. 2006. DC-SIGN association with the Th2 environment of lepromatous lesions: cause or effect? J. Pathol. 209:182-189. http://dx.doi.org/10.1002/path.1972.
60. Fantuzzi L, Purificato C, Donato K, Belardelli F, Gessani S. 2004. Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional alterations of dendritic cells: a novel mechanism for AIDS pathogenesis. J. Virol. 78:9763-9772. http://dx.doi.org/10.1128/JVI.78.18.9763-9772.2004.
61. Hodges A, Sharrocks K, Edelmann M, Baban D, Moris A, Schwartz O, Drakesmith H, Davies K, Kessler B, McMichael A, Simmons A. 2007. Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat. Immunol. 8:569-577. http://dx.doi.org/10.1038/ni1470.
62. Vanbervliet B, Homey B, Durand I, Massacrier C, Aït Yahia S, de Bouteiller O, Vicari A, Caux C. 2002. Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur. J. Immunol. 32:231-242. doi:10.1002/1521-4141(200201)32:1231::AID-IMMU2313.0.CO;2-8.
63. Smed-Sörensen A, Loré K, Vasudevan J, Louder MK, Andersson J, Mascola JR, Spetz A-L, Koup RA. 2005. Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J. Virol. 79:8861-8869. http://dx.doi.org/10.1128/JVI.79.14.8861-8869.2005.
64. Mitchell P, Germain C, Fiori PL, Khamri W, Foster GR, Ghosh S, Lechler RI, Bamford KB, Lombardi G. 2007. Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect. Immun. 75:810-819. http://dx.doi.org/10.1128/IAI.00228-06.
65. Hansson M, Lundgren A, Elgbratt K, Quiding-Järbrink M, Svennerholm A-M, Johansson E-L. 2006. Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3β) after exposure to Helicobacter pylori. Microbes Infect. 8:841-850. http://dx.doi.org/10.1016/j.micinf.2005.10.007.
66. Martín-Fontecha A, Sebastiani S, Höpken UE, Uguccioni M, Lipp M, Lanzavecchia A, Sallusto F. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198:615-621. http://dx.doi.org/10.1084/jem.20030448.
67. Havens AM, Chiu E, Taba M, Jr, Wang J, Shiozawa Y, Jung Y, Taichman LS, D'Silva NJ, Gopalakrishnan R, Wang C. 2008. Stromal-derived factor-1+ (CXCL12) levels increase in periodontal disease. J. Periodontol. 79:845-853.
68. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3:687-694. http://dx.doi.org/10.1038/ni813.
69. Kornman KS, Page RC, Tonetti MS. 1997. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol. 2000 14:33-53. http://dx.doi.org/10.1111/j.1600-0757.1997.tb00191.x.
70. Giacona MB, Papapanou PN, Lamster IB, Rong LL, D'Agati VD, Schmidt AM, Lalla E. 2004. Porphyromonas gingivalis induces its uptake by human macrophages and promotes foam cell formation in vitro. FEMS Microbiol. Lett. 241:95-101.
71. Gibson FC, Yumoto H, Takahashi Y, Chou H-H, Genco CA. 2006. Innate immune signaling and porphyromonas gingivalis-accelerated atherosclerosis. J. Dent. Res. 85:106-121. http://dx.doi.org/10.1177/154405910608500202.
72. Angeli V, Llodrá J, Rong JX, Satoh K, Ishii S, Shimizu T, Fisher EA, Randolph GJ. 2004. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21:561-574. http://dx.doi.org/10.1016/j.immuni.2004.09.003.
73. Drakesmith H, Chain B, Beverley P. 2000. How can dendritic cells cause autoimmune disease? Immunol. Today 21:214-217. http://dx.doi.org/10.1016/S0167-5699(00)01610-8.
74. Forner L, Larsen T, Kilian M, Holmstrup P. 2006. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J. Clin. Periodontol. 33:401-407. http://dx.doi.org/10.1111/j.1600-051X.2006.00924.x.
75. Bobryshev YV. 2005. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur. Heart J. 26:1700-1704. http://dx.doi.org/10.1093/eurheartj/ehi282.
76. Steinman RM. 2000. DC-SIGN: a guide to some mysteries of dendritic cells. Cell 100:491-494. http://dx.doi.org/10.1016/S0092-8674(00)80684-4.
77. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni M, Vago L, Mantovani A, Melillo G, Sica A. 2003. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198:1391-1402. http://dx.doi.org/10.1084/jem.20030267.